Patents by Inventor Jatin Narula

Jatin Narula has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12577308
    Abstract: The invention provides antibodies, and antigen-binding fragments thereof, that specifically bind to E-selectin. The invention includes uses, and associated methods of using the antibodies, and antigen-binding fragments thereof.
    Type: Grant
    Filed: February 27, 2023
    Date of Patent: March 17, 2026
    Assignee: Pfizer Inc.
    Inventors: James Reasoner Apgar, Sheryl Rubio Bowley, Joanne Elizabeth-Ayriss Elwell, Laura Lin, Jatin Narula, Chuenlei Parng, Debra Denene Pittman, Swapnil Rakhe, Chihyi Vincent Yu
  • Publication number: 20250257367
    Abstract: The disclosure describes improved vectors, such as adeno-associated virus (AAV) vectors, for expressing beta-gluco-cerebrosidase (GCase) in transduced cells, and use of such vectors to increase the amount of GCase in subjects experiencing a GCase deficiency, such as subjects with Gaucher disease Type 1.
    Type: Application
    Filed: January 18, 2023
    Publication date: August 14, 2025
    Applicant: AstraZeneca Ireland Limited
    Inventors: Robert D. Bell, Ting-Wen Cheng, Jatin Narula, Clark Qun Pan, Suryanarayan Somanathan, David Wayne Souza, Ricardos Tabet
  • Publication number: 20240076386
    Abstract: The invention provides antibodies, and antigen-binding fragments thereof, that specifically bind to E-selectin. The invention includes uses, and associated methods of using the antibodies, and antigen-binding fragments thereof.
    Type: Application
    Filed: February 27, 2023
    Publication date: March 7, 2024
    Inventors: James Reasoner Apgar, Sheryl Rubio Bowley, Joanne Elizabeth-Ayriss Elwell, Laura Lin, Jatin Narula, Chuenlei Parng, Debra Denene Pittman, Swapnil Rakhe, Chihyi Vincent Yu
  • Patent number: 11597770
    Abstract: The invention provides antibodies, and antigen-binding fragments thereof, that specifically bind to E-selectin. The invention includes uses, and associated methods of using the antibodies, and antigen-binding fragments thereof.
    Type: Grant
    Filed: January 21, 2021
    Date of Patent: March 7, 2023
    Assignee: Pfizer Inc.
    Inventors: James Reasoner Apgar, Sheryl Rubio Bowley, Joanne Elizabeth-Ayriss Elwell, Laura Lin, Jatin Narula, Chuenlei Parng, Debra Denene Pittman, Swapnil Rakhe, Chihyi Vincent Yu
  • Publication number: 20210246213
    Abstract: The invention provides antibodies, and antigen-binding fragments thereof, that specifically bind to E-selectin. The invention includes uses, and associated methods of using the antibodies, and antigen-binding fragments thereof.
    Type: Application
    Filed: January 21, 2021
    Publication date: August 12, 2021
    Inventors: James Reasoner Apgar, Sheryl Rubio Bowley, Joanne Elizabeth-Ayriss Elwell, Laura Lin, Jatin Narula, Chuenlei Parng, Debra Denene Pittman, Swapnil Rakhe, Chihyi Vincent Yu